Active ingredientRisedronate Sodium 2.5 HydrateCat. No. P-R067-001CAS 329003-65-8Family · Pharmaceutical analytical standards
Risedronate
A nitrogen-containing bisphosphonate with a pyridine group that slows bone resorption; approved in the United States in 1998 for Paget's disease and in 2000 for osteoporosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Bisphosphonates mimic natural pyrophosphate, but with a P-C-P bridge that enzymes cannot break: known since 1865, before becoming medicines they were used in industry to prevent limescale deposits.
Go to the active ingredient →Active ingredientRisedronate Sodium 2.5 HydrateCat. No. P-R067-001CAS 329003-65-8
Pharmacopoeial impurityRisedronate EP Impurity ACat. No. P-R067-002CAS 1486466-30-1
Pharmacopoeial impurityRisedronate EP Impurity BCat. No. P-R067-003CAS 105462-23-5
Pharmacopoeial impurityRisedronate EP Impurity CCat. No. P-R067-004CAS 105462-25-7
Pharmacopoeial impurityRisedronate EP Impurity DCat. No. P-R067-005CAS 501-81-5
Pharmacopoeial impurityRisedronate EP Impurity ECat. No. P-R067-006CAS 75755-10-1
Isotopically labelledRisedronic Acid-d4Cat. No. P-R067-007CAS 1035438-80-2
ImpurityRisedronate Related Compound A HydrateCat. No. P-R067-010CAS 1220806-40-5
ImpurityRisedronate Related Compound BCat. No. P-R067-011
Active ingredientRisedronic AcidCat. No. P-R067-012CAS 105462-24-6
Active ingredientRisedronic Acid Monosodium SaltCat. No. P-R067-013CAS 115436-72-1
ImpurityRisedronic Acid N-OxideCat. No. P-R067-014CAS 1630901-84-6
ImpurityTetramethyl RisedronateCat. No. P-R067-015CAS 919355-29-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityRisedronate impurity A CRSEDQM code Y0001558Family RisedronateImpurityRisedronate impurity E CRSEDQM code Y0001540Family RisedronateReference substanceRisedronate sodium 2.5-hydrate CRSEDQM code Y0001541Family RisedronateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.